# Bioavailability Study of Lozanoc™ 65 mg Itraconazole Capsules in Patients Requiring Prophylaxis

> **NCT02755857** · PHASE2 · COMPLETED · sponsor: **Mayne Pharma International Pty Ltd** · enrollment: 20 (actual)

## Conditions studied

- Neutropenia

## Interventions

- **DRUG:** Lozanoc

## Key facts

- **NCT ID:** NCT02755857
- **Lead sponsor:** Mayne Pharma International Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2016-12
- **Final completion:** 2017-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2018-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02755857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02755857, "Bioavailability Study of Lozanoc™ 65 mg Itraconazole Capsules in Patients Requiring Prophylaxis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02755857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*